ES8602790A1 - Procedimiento para preparar pirido (1,2-c)imidazo-(1,2-a) bencimidazoles sustituidos - Google Patents

Procedimiento para preparar pirido (1,2-c)imidazo-(1,2-a) bencimidazoles sustituidos

Info

Publication number
ES8602790A1
ES8602790A1 ES540511A ES540511A ES8602790A1 ES 8602790 A1 ES8602790 A1 ES 8602790A1 ES 540511 A ES540511 A ES 540511A ES 540511 A ES540511 A ES 540511A ES 8602790 A1 ES8602790 A1 ES 8602790A1
Authority
ES
Spain
Prior art keywords
pyridoû1
midazoû1
abenzimidazoles
substituted
preparation
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired
Application number
ES540511A
Other languages
English (en)
Other versions
ES540511A0 (es
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Hoechst AG
Original Assignee
Hoechst AG
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Hoechst AG filed Critical Hoechst AG
Publication of ES8602790A1 publication Critical patent/ES8602790A1/es
Publication of ES540511A0 publication Critical patent/ES540511A0/es
Granted legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D487/00—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, not provided for by groups C07D451/00 - C07D477/00
    • C07D487/02—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, not provided for by groups C07D451/00 - C07D477/00 in which the condensed system contains two hetero rings
    • C07D487/04—Ortho-condensed systems
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D213/00—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members
    • C07D213/02—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members
    • C07D213/04—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen or carbon atoms directly attached to the ring nitrogen atom
    • C07D213/24—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen or carbon atoms directly attached to the ring nitrogen atom with substituted hydrocarbon radicals attached to ring carbon atoms
    • C07D213/44—Radicals substituted by doubly-bound oxygen, sulfur, or nitrogen atoms, or by two such atoms singly-bound to the same carbon atom
    • C07D213/53—Nitrogen atoms
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
    • A61P1/04—Drugs for disorders of the alimentary tract or the digestive system for ulcers, gastritis or reflux esophagitis, e.g. antacids, inhibitors of acid secretion, mucosal protectants
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D213/00—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members
    • C07D213/02—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members
    • C07D213/04—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen or carbon atoms directly attached to the ring nitrogen atom
    • C07D213/24—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen or carbon atoms directly attached to the ring nitrogen atom with substituted hydrocarbon radicals attached to ring carbon atoms
    • C07D213/36—Radicals substituted by singly-bound nitrogen atoms
    • C07D213/38—Radicals substituted by singly-bound nitrogen atoms having only hydrogen or hydrocarbon radicals attached to the substituent nitrogen atom
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D401/00—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom
    • C07D401/02—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings
    • C07D401/06—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings linked by a carbon chain containing only aliphatic carbon atoms
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D471/00—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups C07D451/00 - C07D463/00
    • C07D471/12—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups C07D451/00 - C07D463/00 in which the condensed system contains three hetero rings
    • C07D471/14—Ortho-condensed systems
    • Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y02—TECHNOLOGIES OR APPLICATIONS FOR MITIGATION OR ADAPTATION AGAINST CLIMATE CHANGE
    • Y02P—CLIMATE CHANGE MITIGATION TECHNOLOGIES IN THE PRODUCTION OR PROCESSING OF GOODS
    • Y02P20/00—Technologies relating to chemical industry
    • Y02P20/50—Improvements relating to the production of bulk chemicals
    • Y02P20/55—Design of synthesis routes, e.g. reducing the use of auxiliary or protecting groups

Abstract

PROCEDIMIENTO PARA PREPARAR PIRIDO (1,2-C) IMIDAZO-(1,2-A) BENCIMIDAZOLES SUSTITUIDAS. CARACTERIZADO PORQUE SE TRATAN 2-BENCIMIDAZOL-2-PIRIDIL-SULFOXIDAS DE FORMULA (III), CON UN ACIDO OBTENIENDOSE LOS COMPUESTOS DE FORMULA I.COMPUESTOS UTILES PARA EL TRATAMIENTO DE ULCERAS DE ESTOMAGO Y DUODENO POR INHIBIR LA SECRECION DE ACIDOS GASTRICOS.
ES540511A 1983-09-15 1985-02-19 Procedimiento para preparar pirido (1,2-c)imidazo-(1,2-a) bencimidazoles sustituidos Granted ES540511A0 (es)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
DE19833333314 DE3333314A1 (de) 1983-09-15 1983-09-15 Substituierte pyrido(1,2-c)imidazo(1,2-a)benzimidazole, verfahren zu ihrer herstellung, ihre verwendung sowie pharmazeutische praeparate auf basis dieser verbindungen

Publications (2)

Publication Number Publication Date
ES8602790A1 true ES8602790A1 (es) 1985-12-01
ES540511A0 ES540511A0 (es) 1985-12-01

Family

ID=6209147

Family Applications (2)

Application Number Title Priority Date Filing Date
ES535875A Granted ES535875A0 (es) 1983-09-15 1984-09-13 Procedimiento para preparar pirido (1,2-c) imidazo-(1,2-a)bencimidazoles sustituidos
ES540511A Granted ES540511A0 (es) 1983-09-15 1985-02-19 Procedimiento para preparar pirido (1,2-c)imidazo-(1,2-a) bencimidazoles sustituidos

Family Applications Before (1)

Application Number Title Priority Date Filing Date
ES535875A Granted ES535875A0 (es) 1983-09-15 1984-09-13 Procedimiento para preparar pirido (1,2-c) imidazo-(1,2-a)bencimidazoles sustituidos

Country Status (14)

Country Link
US (1) US4585775A (es)
EP (1) EP0138034B1 (es)
JP (1) JPS6084289A (es)
KR (1) KR850002100A (es)
AT (1) ATE41775T1 (es)
AU (1) AU3306884A (es)
CA (1) CA1247621A (es)
DE (2) DE3333314A1 (es)
DK (1) DK440084A (es)
ES (2) ES535875A0 (es)
GR (1) GR80358B (es)
HU (1) HU194234B (es)
PT (1) PT79200B (es)
ZA (1) ZA847261B (es)

Families Citing this family (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
AR243167A1 (es) 1985-08-24 1993-07-30 Hoechst Ag Procedimiento para la preparacion de toluidinas sustituidas.
DE3639926A1 (de) * 1986-11-22 1988-06-01 Hoechst Ag Substituierte thienoimidazoltoluidin-derivate, verfahren zu ihrer herstellung, sie enthaltende pharmazeutische zubereitungen und ihre verwendung als magensaeuresekretionshemmer
US5008282A (en) * 1988-12-28 1991-04-16 Kotobuki Seiyaku Co. Ltd. Cyclic guanidine derivatives, anti-ulceratives and methods of manufacturing the same
SE9500051D0 (sv) * 1995-01-09 1995-01-09 Frode Rise Antioxidants, tissue- and/or neuroprotectants
RU2645917C1 (ru) * 2017-04-12 2018-03-01 Федеральное государственное бюджетное образовательное учреждение высшего образования "Ярославский государственный университет им. П.Г. Демидова" Способ синтеза пиридо[1,2-а]имидазо[4,5-f]бензимидазола и его производных

Family Cites Families (12)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPS4821274Y1 (es) * 1969-05-31 1973-06-20
JPS5124517B1 (es) * 1971-03-15 1976-07-24
US3880866A (en) * 1972-05-01 1975-04-29 American Home Prod 7-Azaindole fused heterocyclic compounds
US3911130A (en) * 1973-04-18 1975-10-07 American Home Prod Novel 7-azaindole fused heterocyclic compounds for producing analgesia
US3880870A (en) * 1973-04-18 1975-04-29 American Home Prod 7-Azaindole fused heterocyclic compounds
SE416649B (sv) * 1974-05-16 1981-01-26 Haessle Ab Forfarande for framstellning av foreningar som paverkar magsyrasekretionen
SE7804231L (sv) * 1978-04-14 1979-10-15 Haessle Ab Magsyrasekretionsmedel
GB2028317B (en) * 1978-08-15 1982-11-10 Pfizer Ltd 2-(imidazol-1-ylmethyl)-pyridine and -quinoline thromboxane synthetase inhibitors
US4255573A (en) * 1979-03-29 1981-03-10 Adhikary Parimal K Imidazoindole derivatives and pharmaceutical compositions comprising imidazoindole derivatives
JPS56116980A (en) * 1980-02-15 1981-09-14 Nippon Bulge Ind Bend for pipings
US4254127A (en) * 1980-04-03 1981-03-03 Janssen Pharmaceutica, N.V. 1,3-Dihydro-1-[(1-piperidinyl)alkyl]-2H-benzimidazol-2-one derivatives
US4472409A (en) * 1981-11-05 1984-09-18 Byk Gulden Lomberg Chemische Fabrik Gesellschaft Mit Beschrankter Haftung 2-Pyridylmethyl thio(sulfinyl)benzimidazoles with gastric acid secretion inhibiting effects

Also Published As

Publication number Publication date
US4585775A (en) 1986-04-29
GR80358B (en) 1985-01-11
ZA847261B (en) 1985-05-29
DE3477490D1 (en) 1989-05-03
ES8505678A1 (es) 1985-06-01
HU194234B (en) 1988-01-28
EP0138034A1 (de) 1985-04-24
PT79200B (de) 1986-09-10
HUT36120A (en) 1985-08-28
ES535875A0 (es) 1985-06-01
JPS6084289A (ja) 1985-05-13
PT79200A (de) 1984-10-01
ES540511A0 (es) 1985-12-01
ATE41775T1 (de) 1989-04-15
CA1247621A (en) 1988-12-28
DE3333314A1 (de) 1985-03-28
AU3306884A (en) 1985-03-21
DK440084D0 (da) 1984-09-14
EP0138034B1 (de) 1989-03-29
DK440084A (da) 1985-03-16
KR850002100A (ko) 1985-05-06

Similar Documents

Publication Publication Date Title
DK73594A (da) Fremgangsmåde til fremstilling af 17-substituerede 4-aza-5,7-androstadien-3-on-derivater
NO2000010I1 (no) Farmasøytisk akseptable salter av esomeprazol
JPS6425722A (en) Retro virus infection remedy
GB2167298B (en) Pharmaceutical compositions containing inositol triphosphate
RO91197B (ro) Procedeu pentru prepararea unor derivati de piridazinamina
IL91706A0 (en) Pharmaceutical combination compositions comprising a plasminogen activator and hirudin
HUT41809A (en) Process for preparing dideoxy-nucleosides and pharmaceutical compositions containing such compounds
AU2091588A (en) New imidazolidines substituted by a hydroxymethyl radical and a substituted phenyl radical, the process for their preparation, their use as medicaments, the pharmaceutical compositions containing them and an intermediate for their preparation
ES8602790A1 (es) Procedimiento para preparar pirido (1,2-c)imidazo-(1,2-a) bencimidazoles sustituidos
UA27100A1 (uk) Заміщеhі піроли, що мають активhість іhгібіторів протеіhкіhази с, а також їх фармацевтичhо прийhятhі кислотhо-адитивhі солі і фармацевтичhа композиція
HUT52040A (en) Process for producing diaryl-derivatives and pharmaceutical compositions containing them
ZA908131B (en) Gem-diphosphonic acids,a process for the preparation thereof and pharmaceutical compositions containing them
HK134494A (en) Substituted release azelastine containing medicaments
ES8605532A1 (es) Un procedimiento para preparar derivados de aminoglicosido
ZA881053B (en) Prostaglandin e1 derivatives as pharmacologically active agents,and pharmaceutical compositions containing these compounds,especially for transcutaneous administration
US3898330A (en) Corticosteroid phosphate salts/neomycin sulfate ophthalmic
PT86436A (en) Process for preparing pharmaceutical compositions of human calcitonine
AU1495695A (en) Use of aromatic steroids substituted in position 3 by a disubstituted aminoalkyloxy chain in order to obtain a medicament intended to control fertility and in particular male fertility, and the pharmaceutical compositions containing them
ES8504774A1 (es) Procedimiento para preparar derivados de 2-piperacinil-quinazolina
EP0468327A3 (en) Oral pharmaceutical compositions containing hirudin
ZA934110B (en) Diacylglycerol nicotinates, process fot their preparation and the pharmaceutical compositions which contain them
HUT50785A (en) Method for producing intermediate products of anellated azepinone and azocynone derivatives
FR2253518A1 (en) 4-Hydrazino pyrazolo (3,4-b)pyridine-6-carboxylates and derivs - CNS depressants and cyclic AMP increasing agents
AU1621888A (en) Pharmaceutical compositions for the treatment of cerebral psycho-organic syndromes
ES8700858A1 (es) Un procedimiento pra la preparacion de nuevos derivados de 2-dioxacicloalquiltiopenem.